112 related articles for article (PubMed ID: 8242392)
1. Increases of CCK mRNA and peptide in different brain areas following acute and chronic administration of morphine.
Ding XZ; Bayer BM
Brain Res; 1993 Oct; 625(1):139-44. PubMed ID: 8242392
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin (CCK)-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment.
Pohl M; Collin E; Benoliel JJ; Bourgoin S; Cesselin F; Hamon M
Neuropeptides; 1992 Mar; 21(3):193-200. PubMed ID: 1630603
[TBL] [Abstract][Full Text] [Related]
3. Extracellular cholecystokinin levels in the rat spinal cord following chronic morphine exposure: an in vivo microdialysis study.
Lucas GA; Hoffmann O; Alster P; Wiesenfeld-Hallin Z
Brain Res; 1999 Mar; 821(1):79-86. PubMed ID: 10064790
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic treatment with morphine, midazolam and both together on dynorphin(1-13) levels in the rat.
Rattan AK; Tejwani GA
Brain Res; 1997 Apr; 754(1-2):239-44. PubMed ID: 9134981
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin antisense RNA increases the analgesic effect induced by electroacupuncture or low dose morphine: conversion of low responder rats into high responders.
Tang NM; Dong HW; Wang XM; Tsui ZC; Han JS
Pain; 1997 May; 71(1):71-80. PubMed ID: 9200176
[TBL] [Abstract][Full Text] [Related]
6. Effect of pentylenetetrazol treatment on cholecystokinin mRNA and peptide levels in rat hippocampus and cortex.
Takeda K; Nakata K; Takahashi S; Chikuma T; Kato T
Brain Res; 1998 Jan; 779(1-2):320-3. PubMed ID: 9473710
[TBL] [Abstract][Full Text] [Related]
7. Naltrexone-induced alterations of the distribution of morphine in brain regions and spinal cord of the rat.
Bhargava HN; Larsen AK; Rahmani NH; Villar VM
Brain Res; 1993 Apr; 607(1-2):1-8. PubMed ID: 8481789
[TBL] [Abstract][Full Text] [Related]
8. Modulation of preproenkephalin mRNA levels in brain regions and spinal cord of rats treated chronically with morphine.
Gudehithlu KP; Bhargava HN
Peptides; 1995; 16(3):415-9. PubMed ID: 7651893
[TBL] [Abstract][Full Text] [Related]
9. Arthritis-induced increase in cholecystokinin release in the rat anterior cingulate cortex is reversed by diclofenac.
Heilborn U; Rost BR; Arborelius L; Brodin E
Brain Res; 2007 Mar; 1136(1):51-8. PubMed ID: 17229410
[TBL] [Abstract][Full Text] [Related]
10. Distribution of morphine in brain regions, spinal cord and serum following intravenous injection to morphine tolerant rats.
Bhargava HN; Villar VM; Rahmani NH; Larsen AK
Brain Res; 1992 Nov; 595(2):228-35. PubMed ID: 1467968
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of morphine tolerance and dependence by diazepam and its relation to cyclic AMP levels in discrete rat brain regions and spinal cord.
Sheu MJ; Sribanditmongkol P; Santosa DN; Tejwani GA
Brain Res; 1995 Mar; 675(1-2):31-7. PubMed ID: 7796144
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat.
Xu XJ; Puke MJ; Verge VM; Wiesenfeld-Hallin Z; Hughes J; Hökfelt T
Neurosci Lett; 1993 Apr; 152(1-2):129-32. PubMed ID: 8515864
[TBL] [Abstract][Full Text] [Related]
13. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
Kellstein DE; Mayer DJ
Brain Res; 1990 May; 516(2):263-70. PubMed ID: 2364292
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin gene expression in rat amygdaloid neurons: normal distribution and effect of morphine tolerance.
Pu S; Zhuang H; Lu Z; Wu X; Han J
Brain Res Mol Brain Res; 1994 Feb; 21(3-4):183-9. PubMed ID: 8170343
[TBL] [Abstract][Full Text] [Related]
15. Postnatal development of cholecystokinin-like immunoreactivity and its mRNA level in rat brain regions.
Takeda K; Koshimoto H; Uchiumi F; Haun RS; Dixon JE; Kato T
J Neurochem; 1989 Sep; 53(3):772-8. PubMed ID: 2760620
[TBL] [Abstract][Full Text] [Related]
16. Accelerated expression of cholecystokinin gene in the brain of rats rendered tolerant to morphine.
Zhou Y; Sun YH; Zhang ZW; Han JS
Neuroreport; 1992 Dec; 3(12):1121-3. PubMed ID: 1283533
[TBL] [Abstract][Full Text] [Related]
17. Developmental and regional changes of cholecystokinin mRNA in rat brains.
Hasegawa M; Usui H; Araki K; Kuwano R; Takahashi Y
FEBS Lett; 1986 Jan; 194(2):224-6. PubMed ID: 3940896
[TBL] [Abstract][Full Text] [Related]
18. Regional distribution of cholecystokinin messenger RNA in rat brain during development: quantitation and correlation with cholecystokinin immunoreactivity.
De Belleroche J; Bandopadhyay R; King A; Malcolm AD; O'Brien K; Premi BP; Rashid A
Neuropeptides; 1990 Apr; 15(4):201-12. PubMed ID: 2259392
[TBL] [Abstract][Full Text] [Related]
19. Delta(2)-opioid receptor mediation of morphine-induced CCK release in the frontal cortex of the freely moving rat.
Becker C; Hamon M; Cesselin F; Benoliel JJ
Synapse; 1999 Oct; 34(1):47-54. PubMed ID: 10459171
[TBL] [Abstract][Full Text] [Related]
20. Chemical kindling induced by pentylenetetrazol changes cholecystokinin mRNA and peptide levels in rat frontal cortex.
Takeda K; Nakata K; Chikuma T; Ito T; Kato T
Neurosci Lett; 1997 Oct; 234(2-3):115-8. PubMed ID: 9364511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
